The new Axiom 384HT format addresses a current market need by providing
scientists with a very economical method of quickly genotyping samples
across up to 50,000 markers. Scientists can transfer content from Axiom
96-layout arrays used in sequencing validation and GWAS studies to Axiom
384-layout arrays with 100% fidelity and functionality. The
high-throughput assay combined with the Axiom software for automated
genotype calling in diploid and complex polyploid species offers an
elegant and superior platform for routine genotyping applications.
As scientists make progress in decoding the genomes of various human disease states, they can advance their research and commercial objectives by translating those discoveries into applications for routine human disease screening using custom arrays in the 384-layout.
Researchers designing custom genotyping arrays receive design support and expertise from Affymetrix’ team of bioinformatics scientists to ensure streamlined SNP selection and intelligently designed arrays that fulfill the specific objectives of their study. The Axiom genotyping platform is the only platform that offers the capability to genotype 384 samples across 50,000 markers simultaneously and affordably genotype large sample collections quickly.
To learn more about Axiom® Genotyping Solutions, please visit http://www.affymetrix.com/axiom for applications in human diseases research and www.affymetrix.com/agrigenotyping for applications in agrigenomics.
Products mentioned in this release are for research use only. Not for diagnostic procedures.
All statements in this press release that are not historical are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act as amended, including statements regarding
We strive to provide leadership and support, partnering with our customers in pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and non-profit research institutes in their quest for answers toward using biology for a better world.
More than 2,300 microarray systems have been shipped around the world and more than 48,000 peer-reviewed papers have been published citing our technologies.
Vice President, Marketing Services
Vice President, Investor Relations
Most Popular Stories
- Hezbollah Chief's Assassination Claimed by Sunni Group
- Allstate Seeks to Invest in Minority Firms
- SpaceX's Satellite Launch Is 'Game-Changer'
- U.S. Growth Stayed Steady During Shutdown, Fed Says
- Latin Music Conference Turns 25
- Newtown Massacre Heard on 911 Recordings
- Climate Change Early Warning System Urged
- Reid Confident Congress to Pass Immigration Bill
- New Home Sales Shoot up 25 Percent in October
- Guardian Pressured to Stop NSA Stories: Editor